Back to Search Start Over

A rare frameshift mutation in the AGPAT2 gene in a family from gaza with congenital generalized lipodystrophy.

Authors :
Gorin, Kobi
Golomb, Mordechai
Spitzen, Shoshi
Leitersdorf, Eran
Schurr, Daniel
Haj‐Yahia, Arin
Weiss, Ram
Leibowitz, Gil
Durst, Ronen
Source :
Clinical Endocrinology. Aug2020, Vol. 93 Issue 2, p212-214. 3p. 1 Diagram.
Publication Year :
2020

Abstract

The clinical phenotype of patients II-3, II-6 and II-13, with correlation to the deleterious mutation found in the AGPAT2 gene, suggests high probability of type 1 CGL. Homozygosity for the mutation in our pedigree is associated with a severe clinical presentation demonstrated by extremely excessive triglyceride values accompanied with low HDL values, DM resulting in early complication onset and hypoleptinaemia. Together with the characteristic phenotype, and the deleterious mutation, the pathogenicity of this mutation is very likely; heterozygosity for the mutation demonstrate a phenotype consisting of glucose intolerance and hypertriglyceridaemia, which may be considered a partial phenotype. [Extracted from the article]

Details

Language :
English
ISSN :
03000664
Volume :
93
Issue :
2
Database :
Academic Search Index
Journal :
Clinical Endocrinology
Publication Type :
Academic Journal
Accession number :
144619349
Full Text :
https://doi.org/10.1111/cen.14223